Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Cristofanilli

Showing results (411-420 of 442) with videos related to

Pageof 45
Sort By:
Journal of Translational Medicine|July 4, 2012
Considerations in the development of circulating tumor cell technology for clinical useDavid R Parkinson, Nicholas Dracopoli, Brenda Gumbs Petty, et al.
Cancer Discovery|October 27, 2018
Homophilic CD44 Interactions Mediate Tumor Cell Aggregation and Polyclonal Metastasis in Patient-Derived Breast Cancer ModelsXia Liu, Rokana Taftaf, Madoka Kawaguchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2018
Identification of Incidental Germline Mutations in Patients With Advanced Solid Tumors Who Underwent Cell-Free Circulating Tumor DNA SequencingThomas P Slavin, Kimberly C Banks, Darya Chudova, et al.
Journal of Cancer|July 12, 2019
Perspectives on Inflammatory Breast Cancer (IBC) Research, Clinical Management and Community Engagement from the Duke IBC ConsortiumGayathri R Devi, Holly Hough, Nadine Barrett, et al.
ESMO Open|August 28, 2020
Oncological care organisation during COVID-19 outbreakConcetta Elisa Onesti, Hope S Rugo, Daniele Generali, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2005
Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancerAman U Buzdar, Nuhad K Ibrahim, Deborah Francis, et al.
Biorxiv : the Preprint Server for Biology|April 24, 2023
Computational ranking-assisted identification of Plexin-B2 in homotypic and heterotypic clustering of circulating tumor cells in breast cancer metastasisEmma Schuster, Nurmaa Dashzeveg, Yuzhi Jia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2017
Enrichment of PI3K-AKT-mTOR Pathway Activation in Hepatic Metastases from Breast CancerMariaelena Pierobon, Corinne Ramos, Shukmei Wong, et al.
Human Pathology|April 25, 2018
Decreased expression of microRNA-26b in locally advanced and inflammatory breast cancerQingqing Ding, Yan Wang, Zhuang Zuo, et al.
The New England Journal of Medicine|June 2, 2025
First-Line Camizestrant for Emerging <i>ESR1</i>-Mutated Advanced Breast CancerFrançois-Clément Bidard, Erica L Mayer, Yeon Hee Park, et al.
Pageof 45

Showing results (411-420 of 442) with videos related to

Sort By:
Pageof 45
Journal of Translational Medicine|July 4, 2012
Considerations in the development of circulating tumor cell technology for clinical useDavid R Parkinson, Nicholas Dracopoli, Brenda Gumbs Petty, et al.
Cancer Discovery|October 27, 2018
Homophilic CD44 Interactions Mediate Tumor Cell Aggregation and Polyclonal Metastasis in Patient-Derived Breast Cancer ModelsXia Liu, Rokana Taftaf, Madoka Kawaguchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2018
Identification of Incidental Germline Mutations in Patients With Advanced Solid Tumors Who Underwent Cell-Free Circulating Tumor DNA SequencingThomas P Slavin, Kimberly C Banks, Darya Chudova, et al.
Journal of Cancer|July 12, 2019
Perspectives on Inflammatory Breast Cancer (IBC) Research, Clinical Management and Community Engagement from the Duke IBC ConsortiumGayathri R Devi, Holly Hough, Nadine Barrett, et al.
ESMO Open|August 28, 2020
Oncological care organisation during COVID-19 outbreakConcetta Elisa Onesti, Hope S Rugo, Daniele Generali, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2005
Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancerAman U Buzdar, Nuhad K Ibrahim, Deborah Francis, et al.
Biorxiv : the Preprint Server for Biology|April 24, 2023
Computational ranking-assisted identification of Plexin-B2 in homotypic and heterotypic clustering of circulating tumor cells in breast cancer metastasisEmma Schuster, Nurmaa Dashzeveg, Yuzhi Jia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2017
Enrichment of PI3K-AKT-mTOR Pathway Activation in Hepatic Metastases from Breast CancerMariaelena Pierobon, Corinne Ramos, Shukmei Wong, et al.
Human Pathology|April 25, 2018
Decreased expression of microRNA-26b in locally advanced and inflammatory breast cancerQingqing Ding, Yan Wang, Zhuang Zuo, et al.
The New England Journal of Medicine|June 2, 2025
First-Line Camizestrant for Emerging <i>ESR1</i>-Mutated Advanced Breast CancerFrançois-Clément Bidard, Erica L Mayer, Yeon Hee Park, et al.
Pageof 45